Volume 20, Issue 1 Archives - Page 3 of 3

QIAGEN Invests in Early Detection

April 15, 2011/0 Comments/in Volume 20, Issue 1 Executive Briefing Volume 20 /by admin

Venlo, The Netherlands and Melbourne, Australia 4/3/11—QIAGEN has agreed to acquire Cellestis for AUD 341 million ($355 million = AUD 0.96 = $1) in cash, or AUD 3.55 ($3.70) per share, a 24% premium to the closing price on April 1. Cellestis is in the early stages of commercializing diagnostic tests based on its QuantiFERON-CMV […]

The Top 30 Companies of 2010

April 15, 2011/0 Comments/in Volume 20, Issue 1 Articles Volume 20 /by admin

As expected, IBO’s annual list of the top 30 analytical and life science instrument companies was reshuffled in 2010 due to consolidation and the global economic recovery. Several transactions, including Life Technologies’ divestiture of its joint venture MS business to Danaher (see IBO 9/15/09, 2/15/10) and Agilent Technologies’ acquisition of Varian (see IBO 7/31/09, 5/15/10), […]